CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2010; 31(02): 65-68
DOI: 10.4103/0971-5851.71659
CASE REPORT

Giant non-functioning adrenocortical carcinoma: A rare childhood tumor

Viral V Patel
Department of Radiodiagnosis, PramukhSwami Medical College and Shree Krishna Hospital, Karamsad, Gujarat, India
,
Diva S Shah
Department of Radiodiagnosis, PramukhSwami Medical College and Shree Krishna Hospital, Karamsad, Gujarat, India
,
Chandra R Raychaudhari
Department of Radiodiagnosis, PramukhSwami Medical College and Shree Krishna Hospital, Karamsad, Gujarat, India
,
Keyuri B Patel
Department of Radiodiagnosis, PramukhSwami Medical College and Shree Krishna Hospital, Karamsad, Gujarat, India
› Author Affiliations
Source of Support Nil.

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy, especially in children. The overall incidence is approximately 2 cases per million per year. [1] In children, the incidence is 0.3 cases per million per year, except in southern Brazil where the incidence is 3.4-4.2 cases per million per year. [2] We describe a giant nonfunctioning metastasized ACC in a 6-year-old girl who presented with a history of increasing abdominal girth incidentally noticed by her mother since 1 week. Ultrasound abdomen showed a large right suprarenal tumor with calcifications and necrosis. Empty left renal fossa and compensatory enlarged right kidney were seen. Computed tomography (CT) scan revealed a large heterogenously enhancing right suprarenal mass with calcification and necrosis with pulmonary metastasis. Histopathology report from the right suprarenal mass revealed an ACC. With a stage IV disease, the patient died after 2 months from diagnosis.



Publication History

Article published online:
19 November 2021

© 2010. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Norton JA. Adrenal tumors. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. 7 th ed. Philadelphia, PA: Lippincott Williams Wilkins; 2005. p. 1528-39.
  • 2 Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab 1997;82:2027-31.
  • 3 Agrons GA, Lonergan GJ, Dickey GE, Perez-Monte JE. Adrenocortical neoplasms in children: Radiologic-pathologic correlation. Radiographics 1999;19:989-1008.
  • 4 Kishikawa H, Mizuno T, Takagi I, Yamakawa Y, Shimozato T, Honda K, et al. Nonfunctioning adrenocortical carcinoma in a young girl. Jpn J Surg 1985;15:477-82.
  • 5 Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, et al. Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry. J Clin Oncol 2004;22:838-45.
  • 6 Kanmaz T, Demirbilek S, Ozardali I, Safali M, Guran S, Yucesan S. Nonfunctioning adrenocortical carcinoma in a child. Pediatr Pathol Mol Med 2003;22:405-10.
  • 7 Klausner JM, Nakash R, Inbar M, Gutman M, Lelcuk S, Rozin RR. Prolonged fever as a presenting symptom in adrenal tumors. Oncology 1988;45:15-7.
  • 8 Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA. Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 2001;176:755-9.
  • 9 Allolio B, Fassnacht M. Adrenocortical carcinoma: Clinical update. J Clin Endocrinol Metab 2006;91:2027-37.
  • 10 Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 2001;25:891-7.
  • 11 Ohwada S, Izumi M, Kawate S, Hamada K, Toya H, Togo N, et al. Surgical outcome of stage III and IV adrenocortical carcinoma. Jpn J Clin Oncol 2007;37:108-13.
  • 12 Berruti A, Terzolo M, Sperone P, Pia A, Casa SD, Gross DJ, et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: A large prospective phase II trial. Endocr Relat Cancer 2005;12:657-66.
  • 13 Lee JO, Lee KW, Kim CJ, Kim YJ, Lee HE, Kim H, et al. Metastatic adrenocortical carcinoma treated with sunitinib. Jpn J Clin Oncol 2009;39:183-5.
  • 14 Van Ditzhuijsen CI, van de Weijer R, Haak HR. Adrenocortical carcinoma. Neth J Med 2007;65:55-9.